| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/21/2009 | EP2015639A2 Method for treatment of constipation-predominant irritable bowel syndrome |
| 01/21/2009 | EP1924580B1 Non-steroidal compounds useful as glucocorticoid receptor modulators |
| 01/21/2009 | EP1904477B1 Indol-3-carbonyl-spiro-piperidine derivatives as v1a receptor antagonists |
| 01/21/2009 | EP1863792B1 Atp competitive kinase inhibitors |
| 01/21/2009 | EP1846410B1 Dihydroquinazolinones as 5ht modulators |
| 01/21/2009 | EP1845994B1 Combination of methylxanthine compounds and steroids to treat chronic respiratory diseases |
| 01/21/2009 | EP1845777A4 Starch derivatives and other derivatives, production processes therefor, and wound healing applications therefor |
| 01/21/2009 | EP1838663B1 Glycine transport inhibitors |
| 01/21/2009 | EP1791904A4 Method of treating organophosphorous poisoning |
| 01/21/2009 | EP1664026B1 Mitotic kinesin inhibitors |
| 01/21/2009 | EP1663983B1 N-substituted, 6,8-dialkoxy-1,2,3,4-tetrahydro-1h-isoquinoline as potassium channels modulators |
| 01/21/2009 | EP1641262B1 Circuit for processing video signal containing information such as closed caption |
| 01/21/2009 | EP1631277B1 Natural semi-synthetic and synthetic lipid derivatives of ceramide and sphingosine groups, drugs and the medical use thereof in the form of therapeutic agents in particular for dermatology |
| 01/21/2009 | EP1626964B1 New benzimidazole derivatives |
| 01/21/2009 | EP1626731B1 Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity |
| 01/21/2009 | EP1613315B1 Quinoline-2-one-derivatives for the treatment of airways diseases |
| 01/21/2009 | EP1603566B1 Use of isoquinoline derivatives for treating cancer and map kinase related diseases |
| 01/21/2009 | EP1562939B1 Carboxamides |
| 01/21/2009 | EP1549655B1 Substituted bicyclic thiophene derivatives, compostions containing such compounds and methods of use |
| 01/21/2009 | EP1549619B1 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors |
| 01/21/2009 | EP1531816B1 Spirocyclic piperidines as mch1 antagonists and uses thereof |
| 01/21/2009 | EP1517915B1 Prodrugs of excitatory amino acids |
| 01/21/2009 | EP1513500B1 Pharmaceutical preparations for oral administration, containing ion-exchange resins loaded with pradofloxacin and intrinsically viscous gelling agents as thickening agents |
| 01/21/2009 | EP1509523B1 Triazaspiro compounds useful for treating or preventing pain |
| 01/21/2009 | EP1501791B1 Amino acid analogues |
| 01/21/2009 | EP1499610B1 Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them |
| 01/21/2009 | EP1465491B1 Antiseptic compositions and methods |
| 01/21/2009 | EP1444211B1 Quinazoline derivatives as antitumor agents |
| 01/21/2009 | EP1343495B1 Methods of treating anxiety disorders |
| 01/21/2009 | EP1339690B1 N-type calcium channel antagonists for the treatment of pain |
| 01/21/2009 | EP1335973B1 human adenylate cyclase |
| 01/21/2009 | EP1307588B1 Method for diagnosing or determining a risk for psychosis comprising determining an heterozygous mutation of methylenetetrahydrofolate reductase (MTHFR) |
| 01/21/2009 | EP1301192B1 Use of polysulphated cyclodextrins for treating osteoarthritis |
| 01/21/2009 | EP1023907B1 Medicinal compositions with cholesterol-lowering effect |
| 01/21/2009 | EP0993468B1 Compositions and methods for activating genes of interest |
| 01/21/2009 | EP0981352B1 Use of aplidine for the treatment of cardiovascular diseases |
| 01/21/2009 | EP0951466B1 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 01/21/2009 | EP0946155B2 Pharmaceutical composition for treating fecal incontinence |
| 01/21/2009 | EP0850053B1 Erythrocytes loaded with s-nitrosothiol and uses therefor |
| 01/21/2009 | CN201182672Y Novel nano memory alloy intrauterine device |
| 01/21/2009 | CN101351551A Novel protein and DNA encoding the protein |
| 01/21/2009 | CN101351471A Preparation of a crystalline antibiotic substance |
| 01/21/2009 | CN101351467A 3-(substituted amino)-pyrazolo[3,4-d]pyrimidines as EphB and VEGFR2 kinase inhibitors |
| 01/21/2009 | CN101351466A Heterocyclic Janus kinase 3 inhibitors |
| 01/21/2009 | CN101351465A 3 -monosubstituted tropane derivatives as nociceptin receptor ligands |
| 01/21/2009 | CN101351464A 8-[bis-(2-chloro-phenyl)-methyl]-3-phenyl-8-aza-bicyclo [3.2.1] octane-3-carboxylic acid amide as ligand for the nociceptin receptor ORL-1 |
| 01/21/2009 | CN101351463A 2-(benzimidazol-1-yl)-n-(4-phenylthiazol-2-yl) acetamide derivatives useful in treatment of TRPV1 related disorders |
| 01/21/2009 | CN101351462A 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1(VR1) activity |
| 01/21/2009 | CN101351461A Aryl-isoxazol-4-yl-imidazole derivatives |
| 01/21/2009 | CN101351460A Aspartyl protease inhibitors |
| 01/21/2009 | CN101351455A Macrocyclic compounds useful as BACE inhibitors |
| 01/21/2009 | CN101351453A 杂环酰胺化合物及其用途 The heterocyclic amide compounds and use thereof |
| 01/21/2009 | CN101351452A Hiv整合酶抑制剂 Hiv integrase inhibitors |
| 01/21/2009 | CN101351451A Multicyclic amino acid derivatives and methods of their use |
| 01/21/2009 | CN101351448A Novel 1 -benzyl-4-piperidinamines that are useful in the treatment of COPD and asthma |
| 01/21/2009 | CN101351445A Bicyclic heteroyclic compounds as antiinflammatory or antiallergic agents |
| 01/21/2009 | CN101351444A Novel pyrrole derivates with histone deacetylation enzyme inhibition activity |
| 01/21/2009 | CN101351231A Small interfering ribonucleic acid duplexes comprising arabinose modified nucleotides |
| 01/21/2009 | CN101351227A Pharmaceutical composition for application to nail |
| 01/21/2009 | CN101351215A A method of treatment |
| 01/21/2009 | CN101351211A Triterpenequinone and triterpenephenol derivatives and their application for the treatment of tumors and parasitic diseases |
| 01/21/2009 | CN101351210A New use of 11-piperazin-1-yldibenzo [b,f] [1,4] thiazepine or its pharmaceutically acceptable salt and to oral pharmaceutical compositions |
| 01/21/2009 | CN101351209A Pharmaceutical use of substituted amides |
| 01/21/2009 | CN101351208A Reducing cellular cholesterol levels and/or treating or preventing phospholipidosis |
| 01/21/2009 | CN101351207A Compositions and methods for modulating the immune system |
| 01/21/2009 | CN101351206A Therapeutic agent for liver disease and hepatic function- |
| 01/21/2009 | CN101351205A 3, 11b-cis-dihydrotetrabanezine for the treatment of schizophrenia and other psychoses |
| 01/21/2009 | CN101351204A Novel arylamidine derivative, salt thereof and antifungal agent containing those |
| 01/21/2009 | CN101351203A Use of pyrroloquinoline compounds to kill clinically latent microorganisms |
| 01/21/2009 | CN101351202A Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms |
| 01/21/2009 | CN101351201A Pharmaceutical preparation of aqueous solution containing platinum complex |
| 01/21/2009 | CN101351200A Methods for reducing the amount of proinflammatory substance in animal tissue or body fluid |
| 01/21/2009 | CN101351199A Composition for soft contact lens and adsorption suppressing method |
| 01/21/2009 | CN101351198A Combination and method for ensuring dimethoxyphenecillin resistance staphylococcus aureus to be sensitive to benzoxazole cillin |
| 01/21/2009 | CN101351196A Lipophilic vehicle-based dual controlled release matrix system |
| 01/21/2009 | CN101351193A Dry formulations of aripiprazole |
| 01/21/2009 | CN101351192A Wet granulation method for preparing pharmaceutical compositions of aripiprazole |
| 01/21/2009 | CN101351191A Fenofibrate medicinal preparation with improved bioavailability |
| 01/21/2009 | CN101351189A Pharmaceutical composition for the treatment of nail diseases |
| 01/21/2009 | CN101351188A Estrogen compositions and therapeutic methods of use thereof |
| 01/21/2009 | CN101351180A Testosterone stabilisation in transdermal devices |
| 01/21/2009 | CN101348824A Neurocyte protective agent |
| 01/21/2009 | CN101348812A Lichenin, and preparation and use thereof |
| 01/21/2009 | CN101348569A Organotin coordination polymeric compound, preparation and use thereof |
| 01/21/2009 | CN101348527A Production and powdering process of sodium carboxymethylstarch, and use thereof |
| 01/21/2009 | CN101348515A Use of starfish saponin compound |
| 01/21/2009 | CN101348514A Use of starfish saponin compound extracted from Culcita novaeguineae |
| 01/21/2009 | CN101348513A Ganoderic acid extraction method and preparation of soft capsule of ganoderic acid |
| 01/21/2009 | CN101348511A Synthesis and refinement of nelarabine |
| 01/21/2009 | CN101348509A 2-aryl-6-arylí»-glucoside compound, and preparation and use thereof |
| 01/21/2009 | CN101348504A Ruthenium mixed-polypyridyl complex, preparation thereof and use as antitumor drug |
| 01/21/2009 | CN101348503A O,Oí»-amino malonate and N, O-amino malonate platinum complex compound |
| 01/21/2009 | CN101348495A Thiazolo-[3,2-a] pyridine compound and use thereof as Bcl-2 family protein antagonist |
| 01/21/2009 | CN101348494A High-purity cefmenoxime hydrochloride and preparation thereof |
| 01/21/2009 | CN101348493A High-purity medicament and preparation thereof |
| 01/21/2009 | CN101348492A High-purity ceftizoxime sodium and preparation thereof |
| 01/21/2009 | CN101348482A 3-amido-4-indole maleimide compound, preparation and use thereof |
| 01/21/2009 | CN101348477A Novel pravastatin lactone crystal form |
| 01/21/2009 | CN101348467A Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 01/21/2009 | CN101348461A N-(3-pyridine formyloxy)-3,5-dimethyl-1-amantadine for curing senile dementia or pharmaceutical salt thereof |